GlassScriptPhysician profile
Ashley N Tate
NPI 1861762767
$2,273.68
in general payments reported to CMS, 2019-2025
28 companies · $372 in 2025
The $372 reported for 2025 was more than what 75% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $408 · 2022: $669 · 2023: $413 · 2024: $413 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $371.10 | 2021-2024 | |
| Aspira Women'S Health INC | $224.94 | 2022-2023 | Ova1 |
| Exeltis, USA INC. | $157.33 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $152.22 | 2021-2024 | |
| Novo Nordisk INC | $150.43 | 2021-2025 | Saxenda, Wegovy |
| Axonics, INC. | $126.95 | 2021-2023 | Axonics |
| Organon LLC | $120.52 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $118.94 | 2021-2023 | |
| Sage Therapeutics, LLC | $116.47 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $108.30 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $75.37 | 2023-2024 | Accrufer |
| Mylan Pharmaceuticals INC. | $68.04 | 2021-2022 | |
| Channel Medsystems, INC. | $61.82 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.99 | 2022 | |
| Coopersurgical, INC. | $51.17 | 2022-2024 | Paragard T 380a, Paragard T 380a |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $48.67 | 2024-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Aptima |
| Boston Scientific Corporation | $47.25 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Solyx Sis System |
| Exact Sciences Corporation | $45.04 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $25.08 | 2022 | |
| Lilly USA, LLC | $21.11 | 2025 | Mounjaro |
| Amgen INC. | $19.38 | 2025 | Evenity |
| Agile Therapeutics, INC. | $18.88 | 2022 | |
| Solventum Corporation | $18.23 | 2024 | Prevena |
| Pfizer INC. | $17.09 | 2024 | |
| Dysis Medical, INC. | $15.52 | 2022 | |
| Smith+Nephew, INC. | $14.98 | 2021 | |
| Teleflex LLC | $14.10 | 2021 | |
| Avion Pharmaceuticals | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Tate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.